# Resuscitative EndoVascular Aortic Occlusion for Maximal Perfusion

> **NCT03703453** · EARLY_PHASE1 · COMPLETED · sponsor: **Yale University** · enrollment: 5 (actual)

## Conditions studied

- Cardiac Arrest

## Interventions

- **DEVICE:** ER-REBOA catheter

## Key facts

- **NCT ID:** NCT03703453
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-01-28
- **Primary completion:** 2021-04-29
- **Final completion:** 2021-04-29
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2021-08-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03703453

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03703453, "Resuscitative EndoVascular Aortic Occlusion for Maximal Perfusion". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03703453. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*